Velocity is the world's leading integrated site organization.
Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.
Simplify everything from site selection to study close-out
Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.
News
Op-ed: How Data is Driving GenAI Solutions in Clinical Trials
By Tyler Beasley, Head of Business Intelligence at Velocity Clinical Research The future of successful clinical trials will be written in data. Generative AI (GenAI) is already transforming how Sponsors, … Read more
Winning Through Scale: How We’re Building Toward $500M Revenue
Investors care about many things, but when they say scale, they mean revenue. Two times, five times, ten times… whatever the directive, it’s centered on revenue growth. For leadership teams, … Read more
Potential Breakthrough to Preserve Lean Muscle Mass During GLP-1-Induced Weight Loss
The loss of lean muscle mass has long been a concern for patients using GLP-1 therapies. New results from the Regeneron Phase 2 COURAGE trial, led by Julio Rosenstock, MD, at Velocity’s … Read more
Julio Rosenstock, MD Lead Author of Phase 2 Trial Results Evaluating Orforglipron Published in Diabetes, Obesity and Metabolism
Julio Rosenstock, MD, was the lead author of Phase 2 trial results evaluating orforglipron, an oral GLP-1 receptor agonist, published in Diabetes, Obesity and Metabolism. The study found that orforglipron … Read more